Abstract
Pallid is one of 12 independent murine mutations with a prolonged bleeding time that are models for human platelet storage pool deficiencies in which several intracellular organelles are abnormal. We have mapped the murine gene for protein 4.2 (Epb4.2) to chromosome 2 where it co–localizes with pallid. Southern blot analyses suggest that pallid is a mutation in the Epb4.2 gene. Northern blot analyses demonstrate a smaller than normal Epb4.2 transcript in affected pallid tissues, such as kidney and skin. This is the first gene defect to be associated with a platelet storage pool deficiency, and may allow the identification of a novel structure or biological pathway that influences granulogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Novak, E.K., Hui, S. & Swank, R.T. Platelet storage pool deficiency in mouse pigment mutations associated with seven distinct genetic loci. Blood 63, 536–544 (1984).
Reddington, M. et al. Immature dense granules in platelets from mice with platelet storage pool disease. Blood 69, 1300–1306 (1987).
Theriault, L.L. & Hurley, L.S. Ultrastructure of developing melanosomes in C57 black and pallid mice. Develop. Biol. 23, 261–275 (1970).
Swank, R.T., Reddington, M., Howlett, O. & Novak, E.K. Platelet storage pool deficiency associated with inherited abnormalities of the inner ear in the mouse pigment mutants muted and mocha. Blood 78, 2036–2044 (1991).
Bennett, V. Spectrin-based membrane skeleton: a multipotential adaptor between plasma membrane and cytoplasm. Physiol. Rev. 70, 1029–1065 (1990).
Bennett, V. & Stenbuck, P.J. Association between ankyrin and the cytoplasmic domain of band 3 isolated from the human erythrocyte membrane. J. biol. Chem. 255, 6424–6432 (1980).
Korsgren, C. & Cohen, C.M. Purification and properties of human erythrocyte band 4.2. Association with the cytoplasmic domain of band 3. J. biol. Chem. 261, 5536–5543 (1986).
Korsgren, C. & Cohen, C.M. Associations of human erythrocyte band 4.2. Binding to ankyrin and to the cytoplasmic domain of band 3. J. biol. Chem. 263, 10212–10218 (1988).
Friedrichs, B., Koob, R., Kraemer, D. & Drenckhahn, D. Demonstration of immunoreactive forms of erythrocyte protein 4.2 in nonerythroid Cells and tissues. Eur. J. Cell Biol. 48, 121–127 (1989).
Risinger, M., Dotimas, E. & Cohen, C.M. Human erythrocyte protein 4.2, a high copy number membrane protein, is N-myristylated. J. biol. Chem. 267, 5680–5685 (1992).
Korsgren, C., Lawler, J., Lambert, S., Speicher, D. & Cohen, C.M. Complete amino acid sequence and homologies of human erythrocyte membrane protein band 4.2. Proc. natn. Acad. Sci. U.S.A. 87, 613–617 (1990).
Sung, L.A. et al. Molecular cloning of human protein 4.2: a major component of the erythrocyte membrane. Proc. natn. Acad. Sci. U.S.A. 87, 955–959 (1990).
Phillips, M.A. et al. Primary structure of keratinocyte transglutaminase. Proc. natn. Acad. Sci. U.S.A. 87, 9333–9337 (1990).
Korsgren, C. & Cohen, C.M. Organization of the gene for human erythrocyte membrane protein 4.2: structural similarities with the gene for the subunit of factor XIII. Proc. natn. Acad. Sci. U.S.A. 88, 4840–4844 (1991).
Phillips, M.A., Stewart, B.E. & Rice, R.N. Genomic structure of keratinocyte transglutaminase. Recruitment of new exon for modified function. J. biol. Chem. 267, 2282–2286 (1992).
Rybicki, A.C., Heath, R., Wolf, J.L., Lubin, B. & Schwartz, R.S. Deficiency of protein 4.2 in erythrocytes from a patient with a Coombs negative hemolytic anemia. J. clin. Invest. 81, 893–901 (1988).
Ideguchi, H., Nishimura, J., Nawata, H. & Hamasaki, N. A genetic defect of erythrocyte band 4.2 protein associated with hereditary spherocytosis. Brit. J. Haematol. 74, 347–353 (1990).
Ghanem, A. et al. A haemolytic syndrome associated with the complete absence of red Cell membrane protein 4.2 in two Tunisian siblings. Brit J. Haematol. 75, 414–420 (1990).
Silver, J. Confidence limits for estimates of gene linkage based on analysis of recombinant inbred strains. J. Hered. 76, 436–440 (1985).
Taylor, B.A. Recombinant inbred strains: use in genetic mapping. in Genetic Variants and Strains of the Laboratory Mouse, 2nd edn (eds Lyon, M.F. & Searle, A.G. ) 773–796 (Oxford University Press, New York, 1989).
Ahmed, F., Lundin, L.G. & Shire, J.G.M. Lysosomal mutations increase susceptibility to anaesthetics. Experientia 45, 1133–1135 (1989).
Novak, E.K. et al. Cocoa: a new mouse model for platelet storage pool deficiency. Brit J. Haematol. 69, 371–378 (1988).
Swank, R.T., Sweet, H.O., Davisson, M.T., Reddington, M. & Novak, E.K. Sandy: a new mouse model for platelet storage pool deficiency. Genet. Res. 58, 51–62 (1991).
Roberts, E. A new mutation in the house mouse (mus musculus). Science 74, 569 (1931).
Lane, P.W. & Lyon, M.F. in Genetic Variants and Strains of the Laboratory Mouse, 2nd edition (eds Lyon, M. F. & Searle, A. G. ) 825–842 (Oxford University Press, New York, 1989).
Flaherty, L. in The Mouse in Biomedical Research, Vol. I, (eds Foster, H.L., Small, J.D. & Fox, J.G. ) 215–222 (Academic Press, New York, 1981).
Conboy, J. et al. Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis II. Determination of molecular genetic origins of rearrangements. J. clin. Invest. 86, 524–530 (1990).
Conboy, J.G., Chan, J.Y., Chasis, J.A., Kan, Y.W. & Mohandas, N. Tissue-and development-specific alternative RNA splicing regulates expression of multiple isoforms of erythroid membrane protein 4.1. J. biol. Chem. 266, 8273–8280 (1991).
McCluer, R.H., Williams, M.A., Gross, S.K. & Meisler, M.H. Testosterone effects on the induction and urinary excretion of mouse kidney glycosphingolipids associated with lysosomes. J. biol. Chem. 256, 13112–13120 (1981).
Novak, E. K. & Swank, R.T. Lysosomal dysfunctions associated with mutations at mouse pigment genes. Genetics 92, 189–204 (1979).
Novak, E.K., Wieland, F., Jahreis, G.P. & Swank, R.T. Altered secretion of kidney lysosomal enzymes in the mouse pigment mutants ruby-eye, ruby-eye2J, and maroon. Biochem. Genet. 18, 549–561 (1980).
Meisler, M. Synthesis and secretion of kidney ß-galactosidase in mutant le/le mice. J. biol. Chem. 253, 3129–3134 (1978).
Novak, E.K., Swank, R.T. & Meisler, M.H. Pigmentation and lysosome function in mice homozygous for both pale ear and Belge-J pigment genes. Genet. Res. 35, 195–204 (1980).
Depinho, R.A. & Kaplan, K.L. The Hermarisky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations. Medicine 64, 192–202 (1985).
Boxer, G.J. et al. Abnormal platelet function in Chediak-Higashi syndrome. Brit J. Haematol 35, 521–533 (1977).
Abo, T., Roder, J.C., Abo, W., Copper, M.D. & Balch, C.M. Natural killer (HNK-1+) Cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology. J. clin. Invest. 70, 193–197 (1982).
Orn, A. et al. Pigment mutations in the mouse which also affect lysosomal functions lead to suppressed natural killer Cell activity. Scand. J. Immunol. 15, 305–310 (1982).
Clark, E.A., Schultz, L.D. & Pollack, S.B. Mutations in mice that influence natural killer (NK) Cell activity. Immunogenetics 12, 601–613 (1981).
Roder, J. & Duwe, A., The beige mutation in the mouse selectively impairs natural killer Cell function. Nature 278, 451–453 (1979).
Lyon, M.F. Absence of otoliths in the mouse: an effect of the pallid mutant. J. Genet. 51, 638–650 (1953).
Southern, E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. molec. Biol. 98, 503–517 (1975).
Peters, L.L. et al. Purkinje Cell degeneration associated with erythroid ankyrin deficiency in nb/nb mice. J. Cell Biol. 114, 114–121, (1991).
White, R.A., Birkenmeier, C.S., Peters, L.L., Barker, J.E. & Lux, S.E. Murine erythrocyte ankyrin cDNA: highly conserved regions of the regulatory domain. Mammaiian Genome 3, 281–285 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
White, R., Peters, L., Adkison, L. et al. The murine pallid mutation is a platelet storage pool disease associated with the protein 4.2 (pallidin) gene. Nat Genet 2, 80–83 (1992). https://doi.org/10.1038/ng0992-80
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0992-80